Advances in Precision Medicine Shaping the Neurocutaneous Disorder Market According to a newly published market research report by 24LifeSciences, global neurocutaneous disorder market was valued at USD 3.5 billion in 2026 and is projected to reach USD 5.9 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.2% during the forecast period. Neurocutaneous disorders, clinically known as phakomatoses, are a group of complex genetic conditions affecting both the nervous system and skin. These syndromes arise from abnormal cell development during the embryonic stage, characterized by the growth of tumors (both benign and malignant) in the skin, brain, spinal cord, and other organs. Prominent conditions within this group include Tuberous Sclerosis (TS), Neurofibromatosis (NF), and Sturge-Weber Syndrome. Their lifelong management requires multidisciplinary care, making this a highly specialized and evolving market segment. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9048/neurocutaneous-disorder-market